Healthcare identification technology developer PDC Healthcare has introduced a new line of Spee-D-Mark skin markers designed for use with digital breast tomosynthesis (DBT) exams.
The 3D DBT skin markers help technologists and radiologists mark and identify moles, scars, palpable masses, and areas of concern with minimal "slinky" artifact on DBT studies, according to the vendor. The new markers join the firm's current Spee-D-Mark skin markers for traditional mammography exams, which have been sold since 1995 under the St. John Companies brand, PDC said.
